
Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation
Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in …